EveliQure focuses on diarrhea, the most common illness in the world today that has over 2 billion cases annually.

The company provides a unique, breakthrough solution based on its state-of-the-art proprietary development platform.

They develop a vaccine to reduce the high disease burden of travelers and to save young children living in resource poor countries.

EveliQure Biotechnologies GmbH
Helmut-Qualtinger-Gasse 2/1
1030 Vienna
Building: MARXBOX – Map

+43 (0) 1 799 01 17 20